Geoffrey von Maltzahn | |
|---|---|
 | |
| Nationality | American |
| Alma mater | Massachusetts Institute of Technology (S.B.) University of California, San Diego (M.S.) Massachusetts Institute of Technology (Ph.D.) |
| Awards | Lemelson-MIT Student Prize (2009) National Inventors Hall of Fame Collegiate Inventors Competition Graduate Prize (2009), Massachusetts Institute of Technology Randolph G Wei Award (2003) |
| Scientific career | |
| Fields | Bioengineering |
Geoffrey von Maltzahn (born July 22, 1980) is an American biological engineer and businessman in the biotechnology and life sciences industry. Von Maltzahn has cofounded companies including Indigo Agriculture,[1] Generate Biomedicines,[2] Seres Therapeutics,[3] Tessera Therapeutics,[4] and Quotient Therapeutics.[5]
- ^ Mabe, Annalise (November 8, 2022). "The Tiny, Unexpected Key to Reversing a Future Food Shortage". The Daily Beast. Retrieved June 3, 2024.
- ^ Brian, Gormley (September 10, 2020). "Flagship Pioneering Hatches a New Biotech Startup, Generate Biomedicines". The Wall Street Journal. Retrieved June 3, 2024.
- ^ Walrath, Rowan (April 19, 2023). "Microbiome Comes of Age". Boston Business Journal. American City Business Journals. Retrieved June 3, 2024.
- ^ Orelli, Brian (July 13, 2020). "From gene editing to gene writing". BioWorld. Clarivate. Retrieved June 3, 2024.
- ^ Bayer, Max (November 21, 2023). "Flagship launches first UK biotech Quotient with genome sequencing platform". Fierce Biotech. Retrieved June 3, 2024.